Telesis Bio, Inc.

Telesis Bio, Inc. is a biotechnology company specializing in automated synthetic biology solutions for both academic and commercial research sectors. Its primary function is to enable rapid, high-fidelity synthesis of DNA and messenger RNA (mRNA) directly within researchers' laboratories, significantly reducing the turnaround time compared to traditional outsourcing methods. The company's flagship BioXp™ platform consolidates and automates complex workflows for DNA and mRNA synthesis, cloning, and amplification, supporting a diverse array of applications such as vaccine development, precision immunotherapy, antibody engineering, and gene therapy. Telesis Bio also provides proprietary reagents, workflow automation software, and custom enzymatic DNA synthesis solutions, with its technologies being widely recognized for accelerating discovery in therapeutic development and molecular diagnostics. Its innovations, such as the industry-standard Gibson Assembly method and exclusive synthetic biology workstations, have positioned Telesis Bio as a significant enabler in the fields of personalized medicine, biologics, and synthetic biology research worldwide.